Medicofarma Biotech SA (WSE:MDB)
Poland
· Delayed Price · Currency is PLN 0.8140
-0.0460 (-5.35%)
At close: Sep 23, 2025
Medicofarma Biotech Revenue
Medicofarma Biotech had revenue of 279.31K PLN in the twelve months ending June 30, 2025, down -79.60% year-over-year. In the year 2024, Medicofarma Biotech had annual revenue of 1.22M with 63.14% growth.
Revenue (ttm)
279.31K
Revenue Growth
-79.60%
P/S Ratio
190.33
Revenue / Employee
18.62K
Employees
20
Market Cap
53.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.22M | 474.05K | 63.14% |
| Dec 31, 2023 | 750.81K | -3.50M | -82.34% |
| Dec 31, 2022 | 4.25M | 915.81K | 27.45% |
| Dec 31, 2021 | 3.34M | -313.69K | -8.59% |
| Dec 31, 2020 | 3.65M | 465.77K | 14.63% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.17B |
| NEUCA | 13.04B |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 560.38M |
| Celon Pharma | 206.34M |
| Selvita | 373.90M |
| Centrum Medyczne ENEL-MED | 762.83M |
| Ryvu Therapeutics | 130.10M |